Stock screenerAll disclosures →
EDGAR →
KTTA
Conviction 4HealthcareScan · Mon, Aug 10, 2026KTTA$0.4878-3.73%
ResistanceSupportVol 14Insider buyVol MA14 286.22K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.4878
Change-3.73%
Gap-0.36%
Rel volume0.16×
Avg volume321.93K
Avg $ vol148.76K
SMA 200.4619
SMA 500.5221
SMA 2000.7588
Price vs 50-6.57%
Price vs 200-35.72%
MA stackbearish
50/200 cross—
Supertrenddown · 0.5664
RSI (14)51
MACD hist0.01
MACD cross—
Stoch %K / %D67 / 61
ADX (14)24
+DI / −DI19 / 13
RSI divergenceBullish
MACD divergenceBullish
ATR %+8.86%
ADR %8.38%
52w high1.47
52w low0.2923
From 52w high-66.82%
Above 52w low+66.88%
New 52w highNo
SqueezeOn · 28d
Bollinger width14.40%
%B0.89
Donchian pos66.63%
Donchian high0.5208
Donchian low0.4219
AVWAP (52w high)1.29
vs AVWAP high-62.27%
AVWAP (52w low)1.06
vs AVWAP low-53.76%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d0.16×
Avg vol (14d)286.22K
Avg vol (20d)321.93K
Avg $ vol (20d)148.76K
Market cap16.3M
RS 3m (vs SPY)-45.38%
RS 6m (vs SPY)-47.59%
RS line new highNo
Trend template1/8
Technical rank19.5
1 week+9.23%
1 month-0.93%
3 months-38.66%
6 months-32.72%
1 year-30.31%
YTD-59.01%
P/E-0.80
P/B0.30
P/S33.50
P/FCF-1.07
EPS-2.91
Div yield—
ROE-37.27%
ROA-36.25%
Debt/Eq—
Current35.40
EV/EBITDA—
Gross margin-0.45%
Net margin—
Rev growth3130.37%
EPS growth-46.91%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-34.1M
Revenue218.61K
Net income-2.87M
Gross profit132.14K
Free cash flow-15.25M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out24.94M
Employees5
ListedWed, Sep 15, 2021
Free float20.26M
Float %81.2%
Short interest242.87K
Days to cover0.6d
Short volume46.6%
Squeeze score10 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank19.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.6049
Support0.4292
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KTTA
No recent disclosed trades by Congress in KTTA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KTTA · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Coastlands Capital LP 10% owner · Common Stock · 2026-06-17 | Buy | 100K | $53K | 2026-06-17 | 2026-06-22 |
Novak Alfred J Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
Dumesnil Simon Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
Marques Tiago Chief Executive Officer · Stock Option (right to buy) · 2026-05-01 | Grant | 1.76M | $0 | 2026-05-01 | 2026-05-05 |
Leahy Emer Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
Schneiderman Daniel H Chief Financial Officer · Stock Option (right to buy) · 2026-05-01 | Grant | 1.13M | $0 | 2026-05-01 | 2026-05-05 |
Krishnan Kartik Chief Medical Officer · Stock Option (right to buy) · 2026-05-01 | Grant | 1.13M | $0 | 2026-05-01 | 2026-05-05 |
STEINMAN LAWRENCE Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
SEC filings
EDGAR filings in KTTA · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.